Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, PRC, Guangzhou 510640, China.
Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, PRC, Guangzhou 510640, China.
Res Vet Sci. 2020 Jun;130:184-192. doi: 10.1016/j.rvsc.2020.03.013. Epub 2020 Mar 7.
Cyprinid herpesvirus 3 (CyHV-3) is the etiological agent of koi herpersvirus disease (KHVD), which causes serious economic losses in global common carp and ornamental koi carp production of larvae as well as adult type fish. To control KHVD, vaccines against CyHV-3 utilizing different immunization routes have been developed, among them, oral vaccination is the most desirable method to prevent fish diseases occurring at the early larval stage. Here, we developed an oral subunit vaccine through the Saccharomyces cerevisiae cell surface display of CyHV-3 envelope protein pORF65, then, the recombinant yeast fed to Artemia which served as bio-encapsulation vector by subsequently feeding the common carp (Cyprinus carpio var. Jian) larvae. The fluorescent observation showed that the Artemia and S. cerevisiae could deliver intact antigen to the hindgut of carp larvae suggesting the possibility of the vector for oral immunization. On this basis, after three immunizations at a week interval, the oral vaccine induced high level of specific anti-pORF65 antibody. Meanwhile, a significant difference of immune-related genes expression occurred including cxca, IL-1β, IFN-a1, lysozyme, IgM and CD8α between vaccined group and blank control group. In addition, 30% of relative percent survival of carp larvae after immunization was obtained post the animal infection assay, offered an certain immune protection. Our results indicated that the oral pORF65 subunit vaccine bioencapsulated in Artemia induced the activation of immune response and high level of antibodies, which could be served as an oral vaccine candidate for the prevention of CyHV-3 infection.
鲤鱼疱疹病毒 3(CyHV-3)是锦鲤疱疹病毒病(KHVD)的病原体,它导致全球鲤鱼和观赏鲤鱼幼虫以及成年鱼类的生产中遭受严重的经济损失。为了控制 KHVD,已经开发了针对 CyHV-3 的利用不同免疫途径的疫苗,其中,口服免疫是预防早期幼鱼期发生鱼类疾病的最理想方法。在这里,我们通过酵母细胞表面展示 CyHV-3 包膜蛋白 pORF65 开发了一种口服亚单位疫苗,然后,将重组酵母作为生物包封载体喂养丰年虾,随后再喂养鲤鱼(Cyprinus carpio var. Jian)幼鱼。荧光观察表明,丰年虾和酵母可以将完整的抗原递送到鲤鱼幼鱼的后肠,这表明该载体具有口服免疫的可能性。在此基础上,经过三周一次的三次免疫后,口服疫苗诱导了高水平的特异性抗 pORF65 抗体。同时,在免疫相关基因表达方面也发生了显著差异,包括 cxca、IL-1β、IFN-a1、溶菌酶、IgM 和 CD8α。此外,在动物感染试验后,获得了 30%的鲤鱼幼鱼相对存活率,提供了一定的免疫保护。我们的结果表明,口服包封在丰年虾中的 pORF65 亚单位疫苗诱导了免疫反应的激活和高水平的抗体,可作为预防 CyHV-3 感染的口服疫苗候选物。